You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (10)

Journals (0)

1-10 of 10 results for FLT3 positive AML

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Isavuconazole therapy in an FLT3 mutated acute myeloid leukemia patient receiving midostaurin: A case report

Retricted access

Case report

First published 2019-6

Isavuconazole therapy in an FLT3 mutated acute myeloid leukemia patient receiving midostaurin: A case report

Eris Tollkuci

Journal of Oncology Pharmacy Practice

Select article: Midostaurin in Combination With Standard Chemotherapy for Treatment of Newly Diagnosed FMS-Like Tyrosine Kinase 3 (FLT3) Mutation–Positive Acute Myeloid Leukemia

Retricted access

Review article

First published 2018-4

Midostaurin in Combination With Standard Chemotherapy for Treatment of Newly Diagnosed FMS-Like Tyrosine Kinase 3 (FLT3) Mutation–Positive Acute Myeloid Leukemia

Miryoung Kim, Sherry Williams

Annals of Pharmacotherapy

Select article: Clinical Characteristics and Outcomes of Acute Myeloid Leukemia Patients Harboring NPM1/FLT3-ITD/DNMT3A Triple Mutations and the Potential Prognostic Value of GNG4

Open access

Research article

First published 2025-07

Clinical Characteristics and Outcomes of Acute Myeloid Leukemia Patients Harboring NPM1/FLT3-ITD/DNMT3A Triple Mutations and the Potential Prognostic Value of GNG4

Yujie Niu, Xingchun Luo, Xiaoxiao Yang [...]

Cancer Control

Select article: Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors

Free access

Research article

First published 2010-10

Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors

Ellen Weisberg, Johannes Roesel, Pascal Furet [...]

Genes & Cancer

Select article: The Potential Transcriptomic and Metabolomic Mechanisms of ATO and ATRA in Treatment of FLT3-ITD Acute Myeloid Leukemia

Open access

Research article

First published 2024

The Potential Transcriptomic and Metabolomic Mechanisms of ATO and ATRA in Treatment of FLT3-ITD Acute Myeloid Leukemia

Chun-Jin Peng, Zhong Fan, Jie-Si Luo [...]

Technology in Cancer Research & Treatment

Select article: Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia

Retricted access

Case report

First published 2019-12

Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia

Seiji Kakiuchi, Kimikazu Yakushijin, Rina Sakai [...]

Journal of Oncology Pharmacy Practice

Select article: PTBP1 is a potential indicator of disease progression in acute myeloid leukemia

Retricted access

Research article

First published 2024-12

PTBP1 is a potential indicator of disease progression in acute myeloid leukemia

Lina Xing, Xuefei Guo, Xiaolei Zhang [...]

Journal of Investigative Medicine

Select article: Gilteritinib administration in a hemodialysis patient

Retricted access

Case report

First published 2021-7

Gilteritinib administration in a hemodialysis patient

Eris Tollkuci, Tiffany Tran, Rebecca Myers

Journal of Oncology Pharmacy Practice

Select article: Molecular Evaluation of CEBPA Gene Mutation in Normal Karyotype Acute Myeloid Leukemia: A Comparison of Two Methods and Report of Novel CEBPA Mutations from Indian Acute Myeloid Leukemia Patients

Retricted access

Research article

First published 2012-07

Molecular Evaluation of CEBPA Gene Mutation in Normal Karyotype Acute Myeloid Leukemia: A Comparison of Two Methods and Report of Novel CEBPA Mutations from Indian Acute Myeloid Leukemia Patients

Firoz Ahmad, Saket Rajput, Swarna Mandava [...]

Genetic Testing and Molecular Biomarkers

Select article: Venetoclax added to CLAG regimen might improve the outcome of patients with relapsed/refractory acute myeloid leukemia

Open access

Research article

First published 2025

Venetoclax added to CLAG regimen might improve the outcome of patients with relapsed/refractory acute myeloid leukemia

Yu Zhang, Zhao Yin, Zurong Yao [...]

Therapeutic Advances in Hematology

1
10 / page

Article type

Publication date

Subjects

Access